Browsing by Author Kumana, CR

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 125 to 144 of 206 < previous   next >
TitleAuthor(s)Issue DateViews
 
Natriuretic peptides - Relevance in cardiovascular disease
Journal:Journal of the American Medical Association
Cheung, BMYKumana, CR
1998
118
 
Network meta-analysis of cardiovascular outcomes in randomised controlled trials of new antidiabetic drugs
Proceeding/Conference:Seoul International Congress of Endocrinology and Metabolism (SICEM), 2017
FEI, YTSOI, MFKumana, CRCheung, TTCheung, BMY
2017
44
 
Network meta-analysis of cardiovascular outcomes in randomised controlled trials of new antidiabetic drugs
Proceeding/Conference:Clinical Therapeutics
Fei, YTsoi, MFKumana, CRCheung, TTCheung, BMY
2017
73
 
Network meta-analysis of cardiovascular outcomes in randomised controlled trials of new antidiabetic drugs.
Proceeding/Conference:Journal of the Hong Kong College of Cardiology
Fei, YTsoi, MFKumana, CRCheung, TTCheung, BMY
2017
52
 
Network meta-analysis of cardiovascular outcomes in randomized controlled trials of new antidiabetic drugs
Journal:International Journal of Cardiology
FEI, YTSOI, MFKumana, CRCheung, TTCheung, BMY
2018
56
 
Nitroreduction of chloramphenicol succinate in human bone marrow and blood: a possible mechanism responsible of aplastic anaemia
Proceeding/Conference:Hong Kong Practitioner
Ambekar, CSKumana, CRHolt, DCheung, BMYLiang, RHS
1998
78
 
Nitroreduction of Chloramphenicol Succinate in Human Bone Marrow: A Possible Mechanism of Appearance of Aplastic Anaemia
Proceeding/Conference:Joint Meeting of the Hong Kong & Shaanxi Pharmacological Societies
Ambekar, CSKumana, CRHolt, DLiang, RHS
1997
93
 
Non-Pharmacological treatment of hypertension
Proceeding/Conference:Hong Kong Practitioner
Cheung, BMYLaw, CYHo, GYYNg, PPYKumana, CRLau, CP
2001
133
 
Non-vitamin K Oral Anticoagulants Versus Warfarin for Patients with Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights
Journal:Cardiovascular Therapeutics
Kumana, CRCheung, BMYSiu, DCWTse, HFLauder, IJ
2016
40
 
Obesity in the Hong Kong cardiovascular risk factor prevalence survey-2 (CRISPS2) cohort
Proceeding/Conference:Medical Research Conference, MRC 2004
Cheung, BMYMan, YBLo, LFChau, FYLaw, CYLam, KSLLam, THWat, NMSTam, SCFCheng, CHKumana, CRLau, CP
2004
83
 
Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and network meta-analysis of randomised controlled trials.
Proceeding/Conference:Seoul International Congress of Endocrinology and Metabolism (SICEM), 2017
FEI, YTSOI, MFKumana, CRCheung, TTCheung, BMY
2017
38
 
Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond
Journal:Frontiers in Oncology
Kumana, CRKwong, YLSingh, GHH
2022
 
Oral Arsenic Trioxide in the Frontline Treatment of Newly-Diagnosed Acute Promyelocytic Leukemia: A 5-Year Prospective Cohort Study
Proceeding/Conference:Blood
Gill, HKumana, CRKwong, YL
2018
350
 
Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukaemia
Proceeding/Conference:Hong Kong Medical Journal
Au, WYKumana, CRKou, MMak, RChan, GCFLam, CWKwong, YL
2003
82
 
Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia [1]
Journal:Blood
Au, WYKumana, CRKou, MMak, RChan, GCFLam, CWKwong, YL
2003
132
 
Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study
Journal:Cancer
Singh, GHHKumana, CRYim, RLHHwang, YYGChan, SYTYip, SFLee, HKKMak, VLau, JSMChan, CCKho, BWong, RSMLi, WLin, SYLau, CKIp, HWLeung, RYYLam, CCKKwong, YL
2019
67
 
Oral arsenic trioxide, all‐trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long‐term results and unique prognostic indicators
Journal:Cancer
Singh, HSGYim, RYKumana, CRTse, EKwong, Y-L
2020
42
 
Oral Arsenic Trioxide, ATRA and Ascorbic Acid (AAA) Maintenance Following First Complete Remission in Acute Promyelocytic Leukemia - Long-Term Data and Unique Prognostic Indicators
Proceeding/Conference:Blood
Singh, GHHYim, RLHKumana, CRKwong, YL
2019
164
 
Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: A 10-year follow-up study
Journal:Blood
Au, WYKumana, CRLee, HKKLin, SYLiu, HYeung, DYMLau, JSMKwong, YL
2011
158
 
An overview of 1995/96 clinical pharmacology research
Kumana, CR
1996
87
Showing results 125 to 144 of 206 < previous   next >